Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chondroitin sulfate proteoglycan 4 pseudogene 13 (CSPG4P13)
- Target
- CSPG4P13
- Molecular classification
- Other (Pseudogene)
01
Overview
Chondroitin sulfate proteoglycan 4 pseudogene 13 (CSPG4P13) is a non-functional pseudogene related to the CSPG4 gene[2]. It is primarily characterized by its lack of protein-coding capability and is annotated as a pseudogene in major gene databases[2]. While some pseudogenes play regulatory roles, such as acting as microRNA decoys, no specific function or clinical relevance has been described for CSPG4P13[1][4]. In transcriptomic profiling, CSPG4P13 has been identified as a downregulated pseudogene in certain mesenchymal stromal cell populations from emphysema patients, but the biological consequences of this are presently unknown[1]. There are no known disease associations, pharmacological agents, or therapeutic functions directly linked to CSPG4P13[1][2][3].
- Other names
- CSPG4P13GC15P078171various historical aliases/ids from gene resources
02
Biological functions
Possible regulatory role (such as microRNA decoy), but no direct protein function
03
Disease associations
No direct disease role; potential indirect regulatory influence cannot be excluded, as with some pseudogenes, but this has not been described for CSPG4P13 specifically
Beyond the preview
Go deeper on Chondroitin sulfate proteoglycan 4 pseudogene 13 (CSPG4P13).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chondroitin sulfate proteoglycan 4 pseudogene 13 (CSPG4P13).